European urology oncology

Keyphrases

Publications

2024

Andrew E Amini, Alexandra E Hunter, Aya Almashad, Aileen J Feng, Neel D Patel, Margaret R O'Dea, Shelley R McCormick, Linda H Rodgers, Keyan Salari
Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study. European urology oncology (2024)
Emmanuel Seront, Cédric Reichel, Renaud Lhommel, Bertrand Tombal
A Case Series Study of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Early Evaluation of the Response to Systemic Therapy in Metastatic Renal Cancer. European urology oncology (2024)
Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, Mercedes Marín-Aguilera, Caterina Aversa, Laura Ferrer-Mileo, Samuel García-Esteve, Leonardo Rodríguez-Carunchio, Isabel Trias, Albert Font, Alejo Rodriguez-Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, Montserrat Domènech, Mariona Figols, Joan Carles, Cristina Suárez, Daniel Herrero Rivera, Enrique González-Billalabeitia, Claudia Cívico, Núria Sala-González, Vicenç Ruiz de Porras, Maria J Ribal, Aleix Prat, Begoña Mellado
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. European urology oncology (2024)
Johanna Classon, Abigail Britten, Kanar Alkass, Henrik Druid, Nicole Brenner, Tim Waterboer, Nicholas J Wareham, Effrossyni Gkrania-Klotsas, Jonas Frisén
The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality. European urology oncology (2024)
Jun Xie, Hanxu Guo, Baijun Dong, Wei Chen, Chengqi Jin, Qiufan Xu, Li Ding, Wujianhong Liu, Shengrong Dong, Tingting Zhao, Yang Yu, Changcheng Guo, Xudong Yao, Bo Peng, Bin Yang
Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study. European urology oncology (2024)
Thomas Zilli, Piet Ost
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007. European urology oncology (2024)
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, Alberto Briganti
Re: Ost P, Siva S, Brabrand S, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007. European urology oncology (2024)
Craig Jones, Struan Gray, Michael Brown, Janet Brown, Eugene McCloskey, Bhavan P Rai, Noel Clarke, Ashwin Sachdeva
Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials. European urology oncology (2024)
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Jeffry P Simko, Sandy DeVries, Todd M Morgan, Luis Souhami, Michael C Dobelbower, L Scott McGinnis, Christopher U Jones, Robert T Dess, Kenneth L Zeitzer, Kwang Choi, Alan C Hartford, Jeff M Michalski, Adam Raben, Leonard G Gomella, A Oliver Sartor, Seth A Rosenthal, Howard M Sandler, Daniel E Spratt, Stephanie L Pugh, Osama Mohamad, Andre Esteva, Emmalyn Chen, Edward M Schaeffer, Phuoc T Tran, Felix Y Feng
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. European urology oncology (2024)
Jing Xu, Li Ding, Bin Yang
Re: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, et al. Overall Survival with [ 177 Lu]Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-resistant Prostate Cancer (TheraP): Secondary Outcomes of a Randomised, Open-label, Phase 2 Trial. Lancet Oncol 2024;25:99-107. European urology oncology (2024)
Cem Onal, Aysenur Elmali, Ozan Cem Guler
Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006. European urology oncology (2024)
Edward J Saunders, Tokhir Dadaev, Mark N Brook, Sarah Wakerell, Koveela Govindasami, Reshma Rageevakumar, Nafisa Hussain, Andrea Osborne, Diana Keating, Artitaya Lophatananon, Kenneth R Muir, null null, Burcu F Darst, David V Conti, Christopher A Haiman, Antonis C Antoniou, Rosalind A Eeles, Zsofia Kote-Jarai
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European urology oncology (2024)
Guillaume Ploussard, Eric Barret, Gaëlle Fiard, Louis Lenfant, Bernard Malavaud, Gianluca Giannarini, Christophe Almeras, Richard Aziza, Raphaële Renard-Penna, Jean-Luc Descotes, François Rozet, Jean-Baptiste Beauval, Ambroise Salin, Morgan Rouprêt
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). European urology oncology (2024)
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Jeffry P Simko, Sandy DeVries, Todd M Morgan, Luis Souhami, Michael C Dobelbower, L Scott McGinnis, Christopher U Jones, Robert T Dess, Kenneth L Zeitzer, Kwang Choi, Alan C Hartford, Jeff M Michalski, Adam Raben, Leonard G Gomella, A Oliver Sartor, Seth A Rosenthal, Howard M Sandler, Daniel E Spratt, Stephanie L Pugh, Osama Mohamad, Andre Esteva, Emmalyn Chen, Edward M Schaeffer, Phuoc T Tran, Felix Y Feng
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. European urology oncology (2024)
José Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, Jan Laszkiewicz, Javier Taborda, Júlia Aumatell, Miguel Sanchez Encinas, Giuseppe Basile, Marco Moschini, Jorge Caño-Velasco, Enrique Lopez Perez, Pedro Del Olmo Durán, Andrea Gallioli, Andrzej Tukiendorf, David D'Andrea, Jeremy Yuen-Chun Teoh, Alejandra Serna Céspedes, Renate Pilcher, Luca Afferi, Francesco Del Giudice, Juan Gomez Rivas, Simone Albisinni, Francesco Soria, Guillaume Ploussard, Laura S Mertens, Paweł Rajwa, Ekaterina Laukhtina, Benjamin Pradere, Karl Tully, Félix Guerrero-Ramos, Óscar Rodríguez-Faba, Mario Alvarez-Maestro, Jose Luis Dominguez-Escrig, Tomasz Szydełko, Victoria Gomez Dos Santos, Miguel Ángel Jiménez Cidre, Francisco Javier Burgos Revilla, null null
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics. European urology oncology (2024)
Patrick J Hensley, Craig Labbate, Andrew Zganjar, Jeffrey Howard, Heather Huelster, Trey Durdin, Jonathan Pham, Lianchun Xiao, Maximilian Pallauf, Kara Lombardo, Ilya Glezerman, Nirmish Singla, Jay D Raman, Jonathan Coleman, Philippe E Spiess, Vitaly Margulis, Aaron M Potretzke, Surena F Matin
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function. European urology oncology (2024)
Keisuke Shigeta, Kazuhiro Matsumoto, Sotaro Kitaoka, Minami Omura, Kota Umeda, Yuki Arita, Shuji Mikami, Keishiro Fukumoto, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Satoshi Hara, Mototsugu Oya
Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma. European urology oncology (2024)
Eric Wegener, Mark Sidhom, David Pryor, Joseph Bucci, Kenway Yeoh, Matthew Richardson, Peter Greer, Lee Wilton, Sarah Gallagher, Laurel Schmidt, Sankar Arumugam, Sarah Keats, Simon Brown, Alan Glyde, Jarad M Martin
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial. European urology oncology (2024)
Niyati Lobo, Zhigang Duan, Akshay Sood, Wei Shen Tan, Valentina Grajales, Roberto Contieri, Sia V Lindskrog, Lars Dyrskjøt, Hui Zhao, Sharon H Giordano, Stephen B Williams, Kelly K Bree, Ashish M Kamat
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities? European urology oncology (2024)
Marco Bandini, Andrea Salonia, Francesco Montorsi
Re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005. European urology oncology (2024)
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Jeffry P Simko, Sandy DeVries, Todd M Morgan, Luis Souhami, Michael C Dobelbower, L Scott McGinnis, Christopher U Jones, Robert T Dess, Kenneth L Zeitzer, Kwang Choi, Alan C Hartford, Jeff M Michalski, Adam Raben, Leonard G Gomella, A Oliver Sartor, Seth A Rosenthal, Howard M Sandler, Daniel E Spratt, Stephanie L Pugh, Osama Mohamad, Andre Esteva, Emmalyn Chen, Edward M Schaeffer, Phuoc T Tran, Felix Y Feng
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. European urology oncology (2024)
Paramananthan Mariappan, Allan Johnston, Matthew Trail, Sami Hamid, Graham Hollins, Barend A Dreyer, Sara Ramsey, Luisa Padovani, Roberta Garau, Julia Guerrero Enriquez, Alasdair Boden, Gianluca Maresca, Helen Simpson, Rami Hasan, Claire Sharpe, Benjamin G Thomas, Altaf H Chaudhry, Rehan S Khan, Jaimin R Bhatt, Imran Ahmad, Ghulam M Nandwani, Konstantinos Dimitropoulos, Lydia Makaroff, Johnstone Shaw, Catriona Graham, David Hendry, null null
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer. European urology oncology (2024)

volume 7, number 2, 2024

Fumihiko Urabe, Takashi Yoshioka, Takahiro Kimura
Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021. European urology oncology 7 (2) (2024)
Edward J Saunders, Tokhir Dadaev, Mark N Brook, Sarah Wakerell, Koveela Govindasami, Reshma Rageevakumar, Nafisa Hussain, Andrea Osborne, Diana Keating, Artitaya Lophatananon, Kenneth R Muir, null null, Burcu F Darst, David V Conti, Christopher A Haiman, Antonis C Antoniou, Rosalind A Eeles, Zsofia Kote-Jarai
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European urology oncology 7 (2) (2024)
Edward J Saunders, Tokhir Dadaev, Mark N Brook, Sarah Wakerell, Koveela Govindasami, Reshma Rageevakumar, Nafisa Hussain, Andrea Osborne, Diana Keating, Artitaya Lophatananon, Kenneth R Muir, null null, Burcu F Darst, David V Conti, Christopher A Haiman, Antonis C Antoniou, Rosalind A Eeles, Zsofia Kote-Jarai
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European urology oncology 7 (2) (2024)
Fumihiko Urabe, Takashi Yoshioka, Takahiro Kimura
Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021. European urology oncology 7 (2) (2024)
Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz, Axel Heidenreich
Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura's Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021. European urology oncology 7 (2) (2024)
Riccardo Bertolo, Alessandro Antonelli, Andrea Minervini, Riccardo Campi
Off-clamp Versus On-clamp Partial Nephrectomy: Re-envision of a Dilemma. European urology oncology 7 (2) (2024)
Riccardo Bertolo, Alessandro Antonelli, Andrea Minervini, Riccardo Campi
Off-clamp Versus On-clamp Partial Nephrectomy: Re-envision of a Dilemma. European urology oncology 7 (2) (2024)
Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz, Axel Heidenreich
Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura's Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021. European urology oncology 7 (2) (2024)

volume 7, number 3, 2024

David Leung, Daniele Castellani, Rossella Nicoletti, Roser Vives Dilme, Jesus Moreno Sierra, Sergio Serni, Carmine Franzese, Giuseppe Chiacchio, Andrea Benedetto Galosi, Roberta Mazzucchelli, Erika Palagonia, Paolo Dell'Oglio, Antonio Galfano, Aldo Massimo Bocciardi, Xue Zhao, Chi Fai Ng, Hsiang Ying Lee, Shinichi Sakamoto, Nikhil Vasdev, Juan Gomez Rivas, Riccardo Campi, Jeremy Yuen-Chun Teoh
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study. European urology oncology 7 (3) (2024)
Hideaki Miyake, Rikiya Matsumoto, Kiyohide Fujimoto, Atsushi Mizokami, Hirotsugu Uemura, Toshiyuki Kamoto, Satoru Kawakami, Kazuyoshi Nakamura, Shigekatsu Maekawa, Kazuhiro Shibayama, Aki Watanabe, Miku Ito, Yohei Tajima, Hideyasu Matsuyama, Hiroji Uemura
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study. European urology oncology 7 (3) (2024)
Josephine Julie Rosenvilde, Jakob Lauritsen, Mikkel Bandak, Thomas Wagner, Mads Agerbæk, Lars Dysager, Mikael Aagaard, Gedske Daugaard
Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study. European urology oncology 7 (3) (2024)
Cem Onal, Aysenur Elmali, Ozan Cem Guler
Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006. European urology oncology 7 (3) (2024)
Christian Corsini, Oskar Bergengren, Stefan Carlsson, Hans Garmo, Marie Hjelm-Eriksson, Per Fransson, Jon Kindblom, David Robinson, Marcus Westerberg, Pär Stattin, Sigrid V Carlsson
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study. European urology oncology 7 (3) (2024)
David J Benjamin, Arash Rezazadeh Kalebasty, Vinay Prasad
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma? European urology oncology 7 (3) (2024)
David Leung, Daniele Castellani, Rossella Nicoletti, Roser Vives Dilme, Jesus Moreno Sierra, Sergio Serni, Carmine Franzese, Giuseppe Chiacchio, Andrea Benedetto Galosi, Roberta Mazzucchelli, Erika Palagonia, Paolo Dell'Oglio, Antonio Galfano, Aldo Massimo Bocciardi, Xue Zhao, Chi Fai Ng, Hsiang Ying Lee, Shinichi Sakamoto, Nikhil Vasdev, Juan Gomez Rivas, Riccardo Campi, Jeremy Yuen-Chun Teoh
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study. European urology oncology 7 (3) (2024)
Josephine Julie Rosenvilde, Jakob Lauritsen, Mikkel Bandak, Thomas Wagner, Mads Agerbæk, Lars Dysager, Mikael Aagaard, Gedske Daugaard
Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study. European urology oncology 7 (3) (2024)
Roger Li, Luigi Nocera, Kyle M Rose, Daniele Raggi, Shreyas Naidu, Chiara Mercinelli, Antonio Cigliola, Valentina Tateo, Damiano Patanè, G Daniel Grass, Scott M Gilbert, Wade J Sexton, Marco Bandini, Marco Moschini, Alberto Briganti, Francesco Montorsi, Philippe E Spiess, Andrea Necchi
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer. European urology oncology 7 (3) (2024)
Yudai Ishiyama, Fumihiko Urabe
Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002. European urology oncology 7 (3) (2024)
Cem Onal, Aysenur Elmali, Ozan Cem Guler
Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006. European urology oncology 7 (3) (2024)
Christian Corsini, Oskar Bergengren, Stefan Carlsson, Hans Garmo, Marie Hjelm-Eriksson, Per Fransson, Jon Kindblom, David Robinson, Marcus Westerberg, Pär Stattin, Sigrid V Carlsson
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study. European urology oncology 7 (3) (2024)
Olivier Cussenot, Kirsten M Timms, Emmanuel Perrot, Pascal Blanchet, Laurent Brureau, Cara Solimeno, Gaelle Fromont, Eva Comperat, Geraldine Cancel-Tassin
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. European urology oncology 7 (3) (2024)
Christian Corsini, Oskar Bergengren, Stefan Carlsson, Hans Garmo, Marie Hjelm-Eriksson, Per Fransson, Jon Kindblom, David Robinson, Marcus Westerberg, Pär Stattin, Sigrid V Carlsson
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study. European urology oncology 7 (3) (2024)
Giacomo Gallo, Riccardo Lombardo, Cosimo De Nunzio
Re: Hein V. Stroomberg, Signe Benzon Larsen, Torben Kjær Nielsen, J. Thomas Helgstrand, Klaus Brasso, Andreas Røder. Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.005. European urology oncology 7 (3) (2024)
Hideaki Miyake, Rikiya Matsumoto, Kiyohide Fujimoto, Atsushi Mizokami, Hirotsugu Uemura, Toshiyuki Kamoto, Satoru Kawakami, Kazuyoshi Nakamura, Shigekatsu Maekawa, Kazuhiro Shibayama, Aki Watanabe, Miku Ito, Yohei Tajima, Hideyasu Matsuyama, Hiroji Uemura
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study. European urology oncology 7 (3) (2024)

volume 7, number 4, 2024

Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, Mercedes Marín-Aguilera, Caterina Aversa, Laura Ferrer-Mileo, Samuel García-Esteve, Leonardo Rodríguez-Carunchio, Isabel Trias, Albert Font, Alejo Rodriguez-Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, Montserrat Domènech, Mariona Figols, Joan Carles, Cristina Suárez, Daniel Herrero Rivera, Enrique González-Billalabeitia, Claudia Cívico, Núria Sala-González, Vicenç Ruiz de Porras, Maria J Ribal, Aleix Prat, Begoña Mellado
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. European urology oncology 7 (4) (2024)
Akihiro Matsukawa, Takafumi Yanagisawa, Kensuke Bekku, Mehdi Kardoust Parizi, Ekaterina Laukhtina, Jakob Klemm, Sever Chiujdea, Keiichiro Mori, Shoji Kimura, Tamas Fazekas, Marcin Miszczyk, Jun Miki, Takahiro Kimura, Pierre I Karakiewicz, Pawel Rajwa, Shahrokh F Shariat
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis. European urology oncology 7 (4) (2024)
Amy C Justice, Janet P Tate, Frank Howland, J Michael Gaziano, Michael J Kelley, Benjamin McMahon, Christopher Haiman, Roxanne Wadia, Ravi Madduri, Ioana Danciu, John T Leppert, Michael S Leapman, David Thurtle, Vincent J Gnanapragasam
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer. European urology oncology 7 (4) (2024)
Akihiro Matsukawa, Takafumi Yanagisawa, Kensuke Bekku, Mehdi Kardoust Parizi, Ekaterina Laukhtina, Jakob Klemm, Sever Chiujdea, Keiichiro Mori, Shoji Kimura, Tamas Fazekas, Marcin Miszczyk, Jun Miki, Takahiro Kimura, Pierre I Karakiewicz, Pawel Rajwa, Shahrokh F Shariat
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis. European urology oncology 7 (4) (2024)